P

PanCryos

10 employees

PanCryos develops a next generation stem cell derived allogenic cell therapy or Type 1 diabetes.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Biopharma

Date founded

2014

Funding rounds raised

Total raised

$84K

from 1 investors over 1 rounds

P

PanCryos raised $84K on August 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ